Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation

Cutaneous and Ocular Toxicology

Volumn 28, Issue 1, 2009, Pages 45-47

  Balci, Didem Didar ^a   Peker, Erdal ^a   Duran, Nizami ^a   Dogramaci, Cigdem Asena ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Drug induced hypersensitivity syndrome; Human herpesvirus 6 reactivation; Sulfasalazine

Indexed keywords

ACETYLCYSTEINE; CETIRIZINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRESS SYNDROME; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FACE EDEMA; FEVER; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; JUVENILE RHEUMATOID ARTHRITIS; MACULOPAPULAR RASH; MALE; PROGNOSIS; VIRUS REACTIVATION; DRUG EFFECT; DRUG ERUPTION; IMMUNOLOGY; VIRUS INFECTION;

HUMAN HERPESVIRUS 6;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; DRUG ERUPTIONS; HERPESVIRUS 6, HUMAN; HUMANS; MALE; ROSEOLOVIRUS INFECTIONS; SULFASALAZINE;

EID: 70350520736     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520802696250     Document Type: Article

References (13)

1. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been suficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol (2007); 156:1083-1084.
2. Yoshikawa T, Fujita A, Yagami A, Suzuki K, Matsunaga K, Ihira M, Asano Y. Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J Clin Virol (2006); 37(suppl 1):92-96.
3. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol (2007); 157:934-940.
4. Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol (2006); 155:422-428.
5. Michel F, Navellou JC, Ferraut D, Toussirot E, Wendling D. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine (2005); 72:82-85.
6. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest (1988); 82:1826-1832.
7. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg (1996); 15:250-257.
8. Calkin JM, Maibach HI. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis (1993); 29:223-233.
9. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981); 30:239-245.
10. Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics (2001); 108:485-492.
11. Gremse DA, Bancroft J, Moyer MS. Sulfasalazine hyper-sensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia. J Pediatr Gastroenterol Nutr (1989); 9:261-263.
12. Boyer DL, Li BU, Fyda JN, Friedman RA. Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1989); 8:528-532.
13. Conilleau V, Dompmartin A, Verneuil L, Michel M, Leroy D. Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis (1999); 41:141-144.